In the last month, MedMen stock has lost roughly 21%. Yes, the wider market has also suffered, but it’s notable that that decline exacerbated in the last five days as we approached MedMen Enterprises’ (CSE:MMEN) (OTCQX:MMNFF) Pro-forma Q4 release.
The company released its results last night, and now shares are down a further 1.10% selling for a meager $1.80 USD in early morning trade.
Let’s check-in.
MedMen Stock: Will the Results Wreak Havoc?Last night, the company announced unaudited systemwide revenue figures for fiscal Q4 2019. Is also updated investors on “several ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.